Skip to content

Effects of a dairy ingredient on reducing fatigue sensation: a randomized, double-blind, placebo-controlled trial.

Effects of a dairy ingredient on reducing fatigue sensation: a randomized, double-blind, placebo-controlled trial. - Effects of a dairy ingredient on reducing fatigue sensation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058315
Enrollment
132
Registered
2025-06-30
Start date
2025-07-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None (Healthy individuals)

Interventions

Dairy ingredient ingestion for 4 weeks Placebo ingestion for 4 weeks

Sponsors

SOUKEN Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy individuals aged 18-59 years.

Exclusion criteria

Exclusion criteria: 1)Smokers 2)Extremely heavy drinkers (more than 60 g/day of alcohol). 3)Individuals with a persistent or recurrent capacity reduction in conducting daily activities, accompanied by severe fatigue for more than six months. 4)Individuals undergoing treatments for mental and sleep disorders, or chronic fatigue syndrome as well as those with a history of the aforementioned conditions. 5)Individuals exhibiting a serious liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, metabolic system disease as well as those with a chronic disease or serious medical history of the above-described conditions. 6)Individuals displaying a severe food (e.g., milk) or medication allergy as well as those with a significant history of such severe allergies. 7)Pregnant and lactating individuals, or those who expected to be pregnant during the study. 8)Others considered ineligible as research participants in this study, by the principal researcher/doctor based on their background.

Design outcomes

Primary

MeasureTime frame
Fatigue sensation: Visual Analogue Scale (VAS) value

Secondary

MeasureTime frame
OSA sleep inventory MA version score; Swelling sensation (VAS value); Cold sensation (VAS value); Eye fatigue sensation (VAS value); Lower back discomfort (VAS value)

Countries

Japan

Contacts

Public ContactMiwa Kaneko

SOUKEN Co., Ltd. Secretariat

jimukyoku@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026